The National Heart, Lung and Blood Institute has awarded a multi-million dollar grant to Dr. Roberto Bolli of the University of Louisville to form a four-center network examining cardioprotective therapies at the preclinical level.
Bolli is principal investigator of the "CAESAR Project" - a consortium for preclinical assessment of cardioprotective therapies that will involve laboratories at UofL, Johns Hopkins University in Baltimore, Emory University in Atlanta and Virginia Commonwealth University in Richmond.
The four-center project marks the first time the National Institutes of Health has funded a network of laboratories to test cardioprotective therapies at the preclinical level using the same scientific rigor as applied in clinical trials.
The multi-center network being established will be available to all investigators in the nation so that data can be shared with the goal of ultimately translating this type of basic research into clinically applicable therapies for patients with acute myocardial infarction.
At 9 a.m., Friday, Feb. 4, University of Louisville President James Ramsey and representatives of the School of Medicine will conduct a news conference announcing a new National Institutes of Health multi-million dollar grant to create a first-of-its-kind cardiovascular research network.
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses